These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38907928)

  • 21. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P; Xu Y; Zeng C; Ren H; Peng M
    Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and characterization of vinculin-targeted polymer-lipid nanoparticle as intracellular delivery vehicle.
    Wang J; Ornek-Ballanco C; Xu J; Yang W; Yu X
    Int J Nanomedicine; 2013; 8():39-46. PubMed ID: 23293518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.
    Su WP; Cheng FY; Shieh DB; Yeh CS; Su WC
    Int J Nanomedicine; 2012; 7():4269-83. PubMed ID: 22904633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PLGA-carbon nanotube conjugates for intercellular delivery of caspase-3 into osteosarcoma cells.
    Cheng Q; Blais MO; Harris GM; Jabbarzadeh E
    PLoS One; 2013; 8(12):e81947. PubMed ID: 24312611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibility.
    Bertram JP; Jay SM; Hynes SR; Robinson R; Criscione JM; Lavik EB
    Acta Biomater; 2009 Oct; 5(8):2860-71. PubMed ID: 19433141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo.
    Qiao C; Zhang K; Jin H; Miao L; Shi C; Liu X; Yuan A; Liu J; Li D; Zheng C; Zhang G; Li X; Yang B; Sun H
    Int J Nanomedicine; 2013; 8():2985-95. PubMed ID: 23990717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights.
    Hines DJ; Kaplan DL
    Crit Rev Ther Drug Carrier Syst; 2013; 30(3):257-76. PubMed ID: 23614648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Micelle-templated, poly(lactic-
    Nabar GM; Mahajan KD; Calhoun MA; Duong AD; Souva MS; Xu J; Czeisler C; Puduvalli VK; Otero JJ; Wyslouzil BE; Winter JO
    Int J Nanomedicine; 2018; 13():351-366. PubMed ID: 29391794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics.
    Jain AK; Das M; Swarnakar NK; Jain S
    Crit Rev Ther Drug Carrier Syst; 2011; 28(1):1-45. PubMed ID: 21395514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual-Modality Poly-l-histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy.
    Wahane A; Malik S; Shih KC; Gaddam RR; Chen C; Liu Y; Nieh MP; Vikram A; Bahal R
    ACS Appl Mater Interfaces; 2021 Sep; 13(38):45244-45258. PubMed ID: 34524806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SiRNA drug delivery by biodegradable polymeric nanoparticles.
    Yuan X; Li L; Rathinavelu A; Hao J; Narasimhan M; He M; Heitlage V; Tam L; Viqar S; Salehi M
    J Nanosci Nanotechnol; 2006; 6(9-10):2821-8. PubMed ID: 17048488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents.
    Doiron AL; Homan KA; Emelianov S; Brannon-Peppas L
    Pharm Res; 2009 Mar; 26(3):674-82. PubMed ID: 19034628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
    Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
    J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
    Srivastava S; Gupta S; Mohammad S; Ahmad I
    J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of novel coumarin-triazole hybrids and first evaluation of the 4-phenyl substituted hybrid loaded PLGA nanoparticles delivery system to the anticancer activity.
    Arvas B; Ucar B; Acar T; Varli HS; Arvas MB; Aydogan F; Yolacan C
    Nanotechnology; 2024 May; 35(30):. PubMed ID: 38636487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
    Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
    Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
    Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of anti-cancer activity of PLGA nanoparticles containing crocetin.
    Hafezi Ghahestani Z; Alebooye Langroodi F; Mokhtarzadeh A; Ramezani M; Hashemi M
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):955-960. PubMed ID: 27327450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of glucocorticoid receptor small interfering RNA delivered using poly lactic-co-glycolic acid microparticles on proliferation and differentiation capabilities of human mesenchymal stromal cells.
    Hong L; Wei N; Joshi V; Yu Y; Kim N; Krishnamachari Y; Zhang Q; Salem AK
    Tissue Eng Part A; 2012 Apr; 18(7-8):775-84. PubMed ID: 21988716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.